Vitamin E in humans: Demand and delivery

Annual Review of Nutrition

Volumn 16, Issue , 1996, Pages 321-347

  Traber, Maret G ^a   Sies, Helmut ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

ataxia with vitamin E deficiency; chylomicrons; HDL; LDL; lipoproteins; tocopherol; transfer protein; VLDL

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT;

ALPHA TOCOPHEROL DEFICIENCY; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CATARACT; CLINICAL TRIAL; DIABETES MELLITUS; DIET SUPPLEMENTATION; HUMAN; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; LIPOPROTEIN METABOLISM; LIVER METABOLISM; MALABSORPTION; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEFECT; REVIEW; TOTAL PARENTERAL NUTRITION; VITAMIN METABOLISM;

EID: 0029798873     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nu.16.070196.001541     Document Type: Review

References (158)

1. Adams JD Jr, Klaidman LK, Odunze IN, Shen HC, Miller CA. 1991. Alzheimer's and Parkinson's disease, brain levels of glulathione disulfide, and vitamin E. Mol. Chem. Neuropathol. 14: 213-26
2. Arita M, Sato Y, Miyata A, Tanabe T, Takahashi E, et al. 1995. Human alphatocopherol transfer protein: cDNA cloning, expression and chromosomal localization. Biochem. J. 306:437-43
3. Behl C, Davis J, Cole GM, Schubert D. 1992. Vitamin E protects nerve cells from amyloid-β protein toxicity. Biochem. Biophys. Res. Commun. 186:944-50
4. Belal S, Hentati F, Ben Hamida C, Ben Hamida M. 1995. Friedreich's ataxia-vitamin E responsive type. The chromosome 8 locus. Clin. Neurosci. 3: 39-42
5. Ben Hamida C, Doerflinger N, Belal S, Linder C, Reutenauer L, et al. 1993. Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping. Nature Genet. 5:195-200
6. Ben Hamida M, Belal S, Sirugo G, Ben Hamida C, Panayides K, et al. 1993. Friedreich's ataxia phenotype not linked to chromosome 9 and associated with selective autosomal recessive vitamin E deficiency in two inbred Tunisian families. Neurology 43:2179-83
7. Bendich A. 1990. Antioxidant vitamins and their function in immune responses. In Antioxidant Nutrients and Immune Functions, ed. A Bendich, M Phillips, RB Tengerdy, pp. 35-55. New York: Plenum
8. Bendich A, Machlin LJ. 1988. Safety of oral intake of vitamin E. Am. J. Clin. Nutr. 48:612-19
9. Benner SE, Wargovich MJ, Lippman SM, Fisher R, Velasco M, et al. 1994. Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia. Can. Epidemiol. Biomark. Preven. 3:73-76
10. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, et al. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1260-66
11. Biesalski HK. 1995. Antioxidative Vitamine in der Prävention. Dtsch. Ärzteblatt 92:A1316-21
12. Bjørneboe G-EA, Bjørneboe A, Hagen BF, Mørland J, Drevon CA. 1987. Reduced hepatic α-tocopherol after long-term administration of ethanol to rats. Biochim. Biophys. Acta 918:236-41
13. Blaner WS, Obunike JC, Kurlandsky SB, al-Haideri M, Piantedosi R, et al. 1994. Lipoprotein lipase hydrolysis of retinyl ester. Possible implications for retinoid uptake by cells. J. Biol. Chem. 269:16559-65
14. Blomstrand R, Forsgren L. 1968. Labelled tocopherols in man. Int. J. Vitam. Nutr. Res. 38:328-44
15. Blot WJ, Li J-Y, Taylor PR, Guo W, Dawsey S, et al. 1993. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst. 85: 1483-92
16. Boscoboinik D, Szewczyk A, Hensey C, Azzi A. 1991. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 266: 6188-94
17. Bostick RM, Potter JD, McKenzie DR, Sellers TA, Kushi LH, et al. 1993. Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Can. Res. 53:4230-37
18. Bowry VW, Ingold KU, Stocker R. 1992. Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem. J. 288:341-44
19. Brown MS, Goldstein JL. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47
20. Brown MS, Goldstein JL. 1990. Atherosclerosis. Scavenging for receptors. Nature 343:508-9
21. 1-tocopherol and 5-methyltocol. Br. J. Nutr. 15:253-57
22. Burton GW, Ingold KU. 1986. Vitamin E: application of the principles of physical organic chemistry to the exploration of its structure and function. Acc. Chem. Res. 19:194-201
23. Burton GW, Joyce A, Ingold KU. 1983. Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes? Arch. Biochem. Biophys. 221: 281-90
24. Burton GW, Traber MG. 1990. Vitamin E: antioxidant activity, biokinetics and bioavailability. Annu. Rev. Nutr. 10: 357-82
25. Cadenas E, Ginsberg M, Rabe U, Sies H. 1984. Evaluation of alpha-tocopherol antioxidant activity in microsomal lipid peroxidation as detected by low-density chemiluminescence. Biochem. J. 223: 755-59
26. Campbell D, Bunker VW, Thomas AJ, Clayton BE. 1989. Selenium and vitamin E status of healthy and institutionalized elderly subjects: analysis of plasma, erythrocytes and platelets. Br. J. Nutr. 62:221-27
27. Catignani GL, Bieri JG. 1977. Rat liver a-tocopherol binding protein. Biochim. Biophys. Acta 497:349-57
28. Chavance M, Herbeth B, Mikstacki T, Fournier C, Vernhes G, Janot C. 1985. Nutritional support improves antibody response to influenza virus vaccine in the elderly. Br. Med. J. 291:1348-49
29. Cheesemen KH, Holley AE, Kelly FJ, Wasil M, Hughes L, Burton G. 1995. Biokinetics in humans of RRR-α-tocopherol: the free phenol, acetate ester, and succinate ester forms of vitamin E. Free Rad. Biol. Med. 19:591-98
30. Colette C, Pares-Herbute N, Monnier LH, Cartry E. 1988. Platelet function in type I diabetes: effects of supplementation with large doses of vitamin E. Am. J. Clin. Nutr. 47:256-61
31. Cushing SD, Fogelman AM. 1992. Monocytes may amplify their recruitment into inflammatory lesions by inducing monocyte chemotactic protein. Arterioscler. Thromb. 12:78-82
32. de Groot H, Hegi U, Sies H. 1993. Loss of alpha-tocopherol upon exposure to nitric oxide or the sydnonimine SIN-1. Febs Lett. 315:139-42
33. Deckelbaum RJ, Ramakrishnan R, Eisenberg S, Olivecrona T, Bengtsson-Olivecrona G. 1992. Triacylglycerol and phospholipid hydrolysis in human plasma lipoproteins: role of lipoprotein and hepatic lipase. Biochemistry 31: 8544-51
34. DeMaio SJ, King SBd, Lembo NJ, Roubin GS, Hearn JA, et al. 1992. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J. Am. Coll. Nutr. 11:68-73
35. Department of Foods and Nutrition, American Medical Association. 1979. Multivitamin preparations for parenteral use. A statement by the Nutrition Advisory Group. J. Perenter. Enter. Nutr. 3:258-62
36. Dexter DT, Brooks DJ, Harding AE, Burn DJ, Muller DP, et al. 1994. Nigrostriatal function in vitamin E deficiency: clinical, experimental, and positron emission tomographic studies. Ann. Neurol. 35:298-303
37. Dieber-Rotheneder M, Ruhl H, Waeg G, Striegl G, Esterbauer H. 1991. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J. Lipid Res. 32: 1325-32
38. Dimitrov MV, Meyer C, Gilliland D, Ruppenthal M, Chenowith W, Malone W. 1991. Plasma tocopherol concentrations in response to supplemental vitamin E. Am. J. Clin. Nutr. 53:723-29
39. Doerflinger N, Linder C, Ouahchi K, Gyapay G, Weissenbach J, et al. 1995. Ataxia with vitamin E deficiency: refinement of genetic localization and analysis of linkage disequilibrium by using new markers in 14 families. Am. J. Hum. Genet. 56:1116-24
40. Drevon CA. 1991. Absorption, transport and metabolism of vitamin E. Free Rad. Res. Comm. 14:229-46
41. Dyrks T, Dyrks E, Hartmann T, Masters C, Beyreuther K. 1992. Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267: 18210-17
42. Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G, Jürgens G. 1990. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem. Res. Toxicol. 3:77-92
43. Esterbauer H, Gebicki J, Puhl H, Jurgens G. 1992. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Biol. Med. 13: 341-90
44. Evans HM, Bishop KS. 1922. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 56:650-51
45. Fahrenholtz SR, Doleiden FH, Trozzolo AM, Lamola AA. 1974. On the quenching of singlet oxygen by α-tocopherol. Photochem. Photobiol. 20:505-9
46. Fernandez-Calle P, Molina JA, Jimenez-Jimenez FJ, Vazquez A, Pondal M, et al. 1992. Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease. Neurology 42:1064-66
47. Food and Nutrition Board, National Research Council. 1989. Recommended Dietary Allowances. Washington, DC: Natl. Acad. Press. 10th ed.
48. Foote CS, Ching TY, Geller GG. 1974. Chemistry of singlet oxygen - XVIII. Rates of reaction and quenching of α-tocopherol and singlet oxygen. Photochem. Photobiol. 20:511-13
49. Gallo-Torres H. 1970. Obligatory role of bile for the intestinal absorption of vitamin E. Lipids 5:379-84
50. Gey KF, Puska P, Jordan P, Moser UK. 1991. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr. 53: 326S-34S
51. Gillis J, Jones G, Pencharz P. 1983. Delivery of vitamins A, D, and E in total parenteral nutrition solutions. J. Parenter. Enter. Nutr. 7:11-14
52. Gisinger C, Jeremy J, Speiser P, Mikhailidis D, Dandona P, Schernthaner G. 1988. Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial. Diabetes 37:1260-64
53. Granot E, Tamir I, Deckelbaum RJ. 1988. Neutral lipid transfer protein does not regulate α-tocopherol transfer between human plasma lipoproteins. Lipids 23:17-21
54. Hamilton RL. 1994. Apolipoprotein-B-containing plasma lipoproteins in health and in disease. Trends Cardiovasc. Med. 4:131-39
55. Handelman GJ, Epstein WL, Peerson J, Spiegelman D, Machlin LJ. 1994. Human adipose α-tocopherol and γ-tocopherol kinetics during and after 1 y of α-tocopherol supplementation. Am. J. Clin. Nutr. 59:1025-32
56. Harries JT, Muller DPR. 1971. Absorption of different doses of fat soluble and water miscible preparations of vitamin E in children with cystic fibrosis. Arch. Dis. Child. 46:341-44
57. Herz J, Qiu SQ, Oesterle A, DeSilva HV, Shall S, Havel RJ. 1995. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 92:4611-15
58. Hodis HN, Mack WJ, LaBree L, Cashin-Hemphill L, Sevanian A, et al. 1995. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 273:1849-54
59. Homanics GE, Maeda N, Traber MG, Kayden HJ, Dehart DB, Sulik KK. 1995. Exencephaly and hydrocephaly in mice with targeted modification of the apolipoprotein B (Apob) gene. Teratology 51:1-10
60. Homanics GE, Smith TJ, Zhang SH, Lee D, Young SG, Maeda N. 1993. Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice. Proc. Nat. Acad. Sci. USA 90:2389-93
61. Horwitt MK, Elliott WH, Kanjananggulpan P, Fitch CD. 1984. Serum concentrations of α-tocopherol after ingestion of various vitamin E preparations. Am. J. Clin. Nutr. 40:240-45
62. Ingold KU, Bowry VW, Stocker R, Walling C. 1993. Autoxidation of lipids and antioxidation by α-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein Proc. Natl. Acad. Sci. USA 90:45-49
63. Jacques PF, Chylack LT, McGandy RB, Hartz SC. 1988. Antioxidant status in persons with and without senile cataract. Arch. Ophthalmol. 106:337-40
64. Janero DR. 1991. Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis. Free Rad. Biol. Med. 11:129-44
65. Jialal I, Fuller CJ, Huet BA. 1995. The effect of α-tocopherol supplementation on LDL oxidation. A dose-response study. Arterioscler. Thromb. Vasc. Biol. 15:190-98
66. Jialal I, Grundy SM. 1992. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J. Lipid Res. 33:899-906
67. Kaiser S, DiMascio P, Murphy ME, Sies H. 1990. Physical and chemical scavenging of singlet molecular oxygen by tocopherols. Arch. Biochem. Biophys. 227:101-8
68. Kalyanaraman B, Darley-Usmar V, Struck A, Hogg N, Parthasarathy S. 1995. Role of apolipoprotein B-derived radical and α-tocopheroxyl radical in peroxidase-dependent oxidation of low density lipoprotein. J. Lipid Res. 36: 1037-45
69. Kappus H, Diplock A. 1992. Tolerance and safety of vitamin E: a toxicological position report. Free Rad. Biol. Med. 13:55-74
70. Karpen CW, Cataland S, O'Dorisio TM, Panganamala R. 1984. Interrelation of platelet vitamin E and thromboxane synthesis in type I diabetes mellitus. Diabetes 33:239-43
71. Kasparek S. 1980. Chemistry of tocopherols and tocotrienols. In Vitamin E: A Comprehensive Treatise, ed. LJ Machlin, pp. 7-65. New York: Marcel Dekker
72. Kayden HJ, Traber MG. 1991. Abetalipoproteinemia and homozygous hypobetalipoproteinemia. In Primary Hyperlipidemias, ed. G Steiner, E Shafrir, pp. 249-60. New York: McGraw-Hill
73. Kayden HJ, Traber MG. 1993. Absorption, lipoprotein transport and regulation of plasma concentrations of vitamin E in humans. J. Lipid Res. 34:343-58
74. Koletzko B, Decsi T, Sawatzki G. 1995. Vitamin E status of low birthweight infants fed formula enriched with long-chain polyunsaturated fatty acids. Int. J. Vitam. Nutr. Res. 65:101-4
75. Kostner GM, Oettl K, Jauhiainen M, Ehnholm C, Esterbauer H, Dieplinger H. 1995. Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells. Biochem. J. 305: 659-67
76. Krieger M, Herz J. 1994. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63:601-37
77. Kuhlenkamp J, Ronk M, Yusin M, Stolz A, Kaplowitz N. 1993. Identification and purification of a human liver cytosolic tocopherol binding protein. Prot. Exp. Purif. 4:382-89
78. Lackner KJ, Monge JC, Gregg RE, Hoeg JM, Triche TJ, et al. 1986. Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia. J. Clin. Invest. 78: 1707-12
79. Lemoyne M, Van Gossum A, Kurian R, Jeejeebhoy KN. 1988. Plasma vitamin E and selenium and breath pentane in home parenteral nutrition patients. Am. J. Clin. Nutr. 48:1310-15
80. Liebler DC, Burr JA. 1995. Antioxidant stoichiometry and the oxidative fate of vitamin E in peroxyl radical scavenging reactions. Lipids 30:789-93
81. Machlin LJ. 1991. Vitamin E. In Handbook of Vitamins, ed. LJ Machlin, pp. 99-144. New York: Marcel Dekker. 2nd ed.
82. Maitra I, Serbinova E, Tritschler H, Packer L. 1995. α-Lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats. Free Rad. Biol. Med. 18:823-29
83. Massey JB. 1984. Kinetics of transfer of α-tocopherol between model and native plasma lipoproteins. Biochim. Biophys. Acta 793:387-92
84. McCay PB. 1985. Vitamin E: interactions with free radicals and ascorbate. Annu. Rev. Nutr. 5:323-40
85. Meydani SN, Barklund MP, Liu S, Meydani M, Miller RA, et al. 1990. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am. J. Clin. Nutr. 52: 557-63
86. Meydani SN, Meydani M, Rall LC, Morrow F, Blumberg JB. 1994. Assessment of the safety of high-dose, short-term supplementation with vitamin E in healthy older adults. Am. J. Clin. Nutr. 60:704-9
87. Mukai K. 1993. Synthesis and kinetic study of antioxidant and prooxidant actions of vitamin E derivatives. In Vitamin E in Health and Disease, ed. L Packer, J Fuchs, pp. 97-119. New York: Marcel Dekker
88. Muller DP, Goss-Sampson M. 1990. Neurochemical, neurophysiological, and neuropathological studies in vitamin E deficiency. Crit. Rev. Neurobiol. 5: 239-63
89. Nagaoka S, Okauchi Y, Urano S, Nagashima U, Mukai K. 1990. Kinetic and ab initio study of the prooxidant effect of vitamin E. Hydrogen abstraction from fatty acid esters and egg yolk lecithin. J. Am. Chem. Soc. 112:8921-24
90. Nakamura T, Aoyama Y, Fujita T, Katsui G. 1975. Studies on tocopherol derivatives: V. Intestinal absorption of several d,1-3,4-3H2-alpha-tocopheryl esters in the rat. Lipids 10:627-33
91. Neely WC, Martin JM, Barker SA. 1988. Products and relative reaction rates of the oxidation of tocopherols with singlet molecular oxygen. Photochem. Photobiol. 48:423-28
92. Niki E. 1987. Antioxidants in relation to lipid peroxidation. Chem. Phys. Lipids 44:227-53
93. Ouahchi K, Arita M, Kayden H, Hentati F, Ben Hamida M, et al. 1995. Ataxia with isolated vitamin E deficiency is caused by mutations in the α-tocopherol transfer protein. Nature Genet. 9:141-45
94. Paolisso G, Di Maro G, Galzerano D, Cacciapuoti F, Varricchio G, et al. 1994. Pharmacological doses of vitamin E and insulin action in elderly subjects. Am. J. Clin. Nutr. 59:1291-96
95. Paolisso G, Gambardella A, Giugliano D, Galzerano D, Amato L, et al. 1995. Chronic intake of pharmacological doses of vitamin E might be useful in the therapy of elderly patients with coronary heart disease. Am. J. Clin. Nutr. 61:848-52
96. Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJ. 1993. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutarylcoenzyme A reductase. J. Biol. Chem. 268:11230-38
97. Parker RS. 1989. Dietary and biochemical aspects of vitamin E. Adv. Food Nutr. Res. 33:157-232
98. Penn ND, Purkins L, Kelleher J, Heatley RV, Mascie-Taylor BH, Belfield PW. 1991. The effect of dietary supplementation with vitamins A, C and E on cell-mediated immune function in elderly long-stay patients: a randomized controlled trial. Age Ageing 20:169-74
99. Pentland AP, Morrison AR, Jacobs SC, Hruza LL, Hebert JS, Packer L. 1992. Tocopherol analogs suppress arachidonic acid metabolism via phospholipase inhibition. J. Biol. Chem. 267: 15578-84
100. Pillai SR, Traber MG, Kayden HJ, Cox NR, Toivio-Kinnucan M, et al. 1994. Concomitant brain stem axonal dystrophy and necrotizing myopathy in vitamin E-deficient rats. J. Neuro. Sci. 123: 64-73
101. Pillai SR, Traber MG, Steiss JE, Kayden HJ. 1993. Depletion of adipose tissue and peripheral nerve α-tocopherol in adult dogs. Lipids 28:1095-99
102. Pillai SR, Traber MG, Steiss JE, Kayden HJ, Cox NR. 1993. α-Tocopherol concentrations of the nervous system and selected tissues of dogs fed three levels of vitamin E. Lipids 28:1101-5
103. Princen HMG, van Poppel G, Vogelezang C, Buytenhek R, Kok FJ. 1992. Supplementation with vitamin E but not β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking. Arterioscler. Thromb. 12:554-62
104. Rader DJ, Brewer HB. 1993. Abetalipoproteinemia - new insights into lipoprotein assembly and vitamin-E metabolism from a rare genetic disease. JAMA 270:865-69
105. Reaven PD, Witztum JL. 1993. Comparison of supplementation of RRR-α-tocopherol and racemic α-tocopherol in humans. Effects on lipid levels and lipoprotein susceptibility to oxidation. Arterioscler. Thromb. 13:601-8
106. Riemersma RA, Wook DA, MacIntyre CCA, Elton RA, Gey KF, Oliver MF. 1991. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 337:1-5
107. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. 1993. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328:1450-56
108. Robertson JMCD, Donner AP, Trevithick JR. 1989. Vitamin E intake and risk of cataracts in humans. Ann. NY Acad. Sci. 570:372-82
109. Sato Y, Hagiwara K, Arai H, Inoue K. 1991. Purification and characterization of the α-tocopherol transfer protein from rat liver. FEBS Lett. 288:41-45
110. Schaefer EJ, Woo R, Kibata M, Bjornson L, Schreibman PH. 1983. Mobilization of triglyceride but not cholesterol or tocopherol from human adipocytes during weight reduction. Am. J. Clin. Nutr. 37:749-54
111. Schultz M, Leist M, Petrzika M, Gassmann B, Brigelius-Flohé R. 1995. A novel urinary metabolite of α-tocopherol, 2,5,7,8-tetramethyl-2(2′carboxyethyl)-6-hydroxychroman (α-CEHC) as an indicator of an adequate vitamin E supply? Am J. Clin. Nutr. 62 (Suppl.):1527S-34S
112. Sheppard AJ, Pennington JAT, Weihrauch JL. 1993. Analysis and distribution of vitamin E in vegetable oils and foods. In Vitamin E in Health and Disease, ed. L Packer, J Fuchs, pp. 9-31. New York: Marcel Dekker
113. Sies H. 1985. Oxidative stress: introductory remarks. In Oxidative Stress, ed. H Sies, pp. 1-8. London: Academic
114. Sies H, Murphy ME. 1991. Role of tocopherols in the protection of biological systems against oxidative damage. Photochem. Photobiol. 8:211-24
115. Sies H, Stahl W, Sundquist AR. 1992. Antioxidant functions of vitamins (vitamins E and C, beta-carotene, and other carotenoids). Ann. NY Acad. Sci. 669:7-20
116. Sokol RJ. 1993. Vitamin E deficiency and neurological disorders. In Vitamin E in Health and Disease, ed. L Packer, J Fuchs, pp. 815-49. New York: Marcel Dekker
117. Sokol RJ, Heubi JE, Iannaccone S, Bove KE, Harris RE, Balistreri WF. 1983. The mechanism causing vitamin E deficiency during chronic childhood cholestasis. Gastroenterology 85:1172-82
118. Sokol RJ, Kayden HJ, Bettis DB, Traber MG, Neville H, et al. 1988. Isolated vitamin E deficiency in the absence of fat malabsorption - familial and sporadic cases: characterization and investigation of causes. J. Lab. Clin. Med. 111:548-59
119. Sokol RJ, Reardon MC, Accurso FJ, Stall C, Narkewicz M, et al. 1989. Fatsoluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am. J. Clin. Nutr. 50:1064-71
120. Spector A. 1995. Oxidative stress-induced cataract: mechanism of action. FASEB J. 9:1173-82
121. Stampfer MJ, Hennekens C, Manson JE, Colditz GA, Rosner B, Willett WC. 1993. Vitamin E consumption and risk of coronary disease in women. N. Engl. J. Med. 328:1444-49
122. Stauble B, Boscoboinik D, Tasinato A, Azzi A. 1994. Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-alpha-tocopherol in vascular smooth muscle cells. Eur. J. Biochem. 226:393-402
123. Steephen AC, Traber MG, Ito Y, Lewis LH, Kayden HJ, Shike M. 1991. Vitamin E status of patients receiving long term parenteral nutrition: Is vitamin E supplementation adequate? J. Parenter. Enteral Nutr. 15:647-52
124. Steinberg D. 1992. Antioxidants in the prevention of human atherosclerosis. Summ. Proc. NHLBI Workshop Sept 5-6, 1991, Bethesda, Md. Circulation 85:2337-44
125. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-24
126. Steinbrecher UP, Zhang HF, Lougheed M. 1990. Role of oxidatively modified LDL in atherosclerosis. Free Rad. Biol. Med. 9:155-68
127. 1 Δg quenching by α-tocopherol. Photochem. Photobiol. 20:515-17
128. Stocker R, Bowry VW, Frei B. 1991. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc. Natl. Acad. Sci. USA 88: 1646-50
129. Stocker R, Frei B. 1991. Endogenous antioxidant defences in human blood plasma. In Oxidative Stress. Oxidants and Antioxidants, ed. H Sies, pp. 213-43. London: Academic
130. Strickland DK, Kounnas MZ, Argraves WS. 1995. LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J. 9:890-98
131. Tappel AL. 1962. Vitamin E as the biological lipid antioxidant. Vitam. Horm. 20:493-510
132. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. 1994. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330:1029-35
133. The Parkinson Study Group. 1993. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N. Engl. J. Med. 328: 176-83
134. Tohgi H, Abe T, Saheki M, Hamato F, Sasaki K, Takahashi S. 1995. Reduced and oxidized forms of glutathione and alpha-tocopherol in the cerebrospinal fluid of Parkinsonian patients: comparison between before and after L-dopa treatment. Neurosci. Lett. 184:21-24
135. Traber MG. 1994. Determinants of plasma vitamin E concentrations. Free Rad. Biol. Med. 16:229-39
136. Traber MG, Burton GW, Hughes L, Ingold KU, Hidaka H, et al. 1992. Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism. J. Lipid Res. 33:1171-82
137. Traber MG, Burton GW, Ingold KU, Kayden HJ. 1990. RRR- and SRR-α-tocopherols are secreted without discrimination in human chylomicrons, but RRR-α-tocopherol is preferentially secreted in very low density lipoproteins. J. Lipid Res. 31:675-85
138. Traber MG, Carpentier YA, Kayden HJ, Richelle M, Galeano N, Deckelbaum RJ. 1993. Alterations in plasma α- and γ-tocopherol concentrations in response to intravenous infusion of lipid emulsions in humans. Metabolism 42:701-9
139. Traber MG, Cohn W, Muller DPR. 1993. Absorption, transport and distribution to tissues. In Vitamin E in Health and Disease, ed. L Packer, J Fuchs, pp. 35-52. New York: Marcel Dekker
140. Traber MG, Ingold KU, Burton GW, Kayden HJ. 1988. Absorption and transport of deuterium-substituted 2R,4′R, 8′A-α-tocopherol in human lipoproteins. Lipids 23:791-97
141. Traber MG, Kayden HJ. 1984. Vitamin E is delivered to cells via the high affinity receptor for low density lipoprotein. Am. J. Clin. Nutr. 40:747-51
142. Traber MG, Kayden HJ. 1987. Tocopherol distribution and intracellular localization in human adipose tissue. Am. J. Clin. Nutr. 46:488-95
143. Traber MG, Kayden HJ. 1989. Preferential incorporation of α-tocopherol vs γ-tocopherol in human lipoproteins. Am. J. Clin. Nutr. 49:517-26
144. Traber MG, Kayden HJ. 1989. α-Tocopherol as compared with γ-tocopherol is preferentially secreted in human lipoproteins. Ann. NY Acad. Sci. 570:95-108
145. Traber MG, Kayden HJ, Green JB, Green MH. 1986. Absorption of water miscible forms of vitamin E in a patient with cholestasis and in rats. Am. J. Clin. Nutr. 44:914-23
146. Traber MG, Lane JC, Lagmay N, Kayden HJ. 1992. Studies on the transfer of tocopherol between lipoproteins. Lipids 27:657-63
147. Traber MG, Olivecrona T, Kayden HJ. 1985. Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro. J. Clin. Invest. 75:1729-34
148. Traber MG, Packer L. 1995. Vitamin E: beyond antioxidant function. Am. J. Clin. Nutr. 62(Suppl.):1501S-9S
149. Traber MG, Rader D, Acuff R, Brewer HB, Kayden HJ. 1994. Discrimination between RRR- and all rac-α-tocopherols labeled with deuterium by patients with abetalipoproteinemia. Atherosclerosis 108:27-37
150. Traber MG, Ramakrishnan R, Kayden HJ. 1994. Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR-α-tocopherol. Proc. Natl. Acad. Sci. USA 91:10005-8
151. Traber MG, Rudel LL, Burton GW, Hughes L, Ingold KU, Kayden HJ. 1990. Nascent VLDL from liver perfusions of cynomolgus monkeys are preferentially enriched in RRR- compared with SRR-α tocopherol: studies using deuterated to copherols. J. Lipid Res. 31:687-94
152. Traber MG, Sokol RJ, Burton GW, Ingold KU, Papas AM, et al. 1990. Impaired ability of patients with familial isolated vitamin E deficiency to incorporate α-tocopherol into lipoproteins secreted by the liver. J. Clin. Invest. 85: 397-407
153. Traber MG, Sokol RJ, Kohlschütter A, Yokota T, Muller DPR, et al. 1993. Impaired discrimination between stereo-isomers of α-tocopherol in patients with familial isolated vitamin E deficiency. J. Lipid Res. 34:201-10
154. von Herbay A, de Groot H, Hegi U, Stremmel W, Strohmeyer G, Sies H. 1994. Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J. Hepatol. 20:41-46
155. Watanabe J, Umeda F, Wakasugi H, Ibayashi H. 1984. Effect of vitamin E on platelet aggregation in diabetes mellitus. Throm. Haemostas. 51:313-16
156. Wefers H, Sies H. 1988. The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on vitamin E. Eur. J. Biochem. 174:353-57
157. Wetterau JR, Aggerbeck LP, Bouma ME, Eisenberg C, Munck A, et al. 1992. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 258:999-1001
158. Yoshida H, Yusin M, Ren I, Kuhlenkamp J, Hirano T, et al. 1992. Identification, purification and immuno chemical characterization of a tocopherol-binding protein in rat liver cytosol. J. Lipid Res. 33:343-50